M. Beck

The role of the iminosugar N-butyldeoxynojirimycin (miglustat) in the management of type I (non-neuronopathic) Gaucher disease: A position statement

G. Andria, J. M. Aerts, B. Bembi, 2003, Journal of Inherited Metabolic Disease.